कृपया अन्य खोज का प्रयास करें
CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients’ adipose tissues, and to prepare platelet-rich plasma from patients’ blood; and offers support services for medical facilities providing regenerative medicine therapy, as well as manufacturing processed cells. It is also involved in the development and sale of Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Norio Murakami | 77 | 2017 | Independent Outside Director |
Tsuneyasu Ozaki | 55 | 2019 | Independent Outside Director |
Kumi Fujisawa | 57 | - | Independent Outside Director |
Takeshi Amemiya | 62 | 2017 | Director |
Takashi Sawada | 67 | 2022 | Representative Director, President & CEO |
Masayuki Yamakawa | 60 | 2022 | Executive Chairman & MD |
Masato Tsumamoto | 42 | 2024 | Representative Director & Chief Transformation Officer |
Hirohiko Hanaki | 55 | 2017 | Executive Officer & Head of Medical Affairs Headquarters |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है